Geli J - Search Results

1

Detailed assessment of chromosome 22 aberrations in sporadic pheochromocytoma using array-CGH.

Jarbo C, Buckley PG, Piotrowski A, Mantripragada KK, Benetkiewicz M, Diaz de Ståhl T, Langford CF, Gregory SG, Dralle H, Gimm O, Bäckdahl M, Geli J, Larsson C, Westin G, Akerström G, Dumanski JP. Jarbo C, et al. Among authors: geli j. Int J Cancer. 2006 Mar 1;118(5):1159-64. doi: 10.1002/ijc.21385. Int J Cancer. 2006. PMID: 16161042 Free article.

2

Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas.

Geli J, Nord B, Frisk T, Edström Elder E, Ekström TJ, Carling T, Bäckdahl M, Larsson C. Geli J, et al. Int J Oncol. 2005 May;26(5):1385-91. Int J Oncol. 2005. PMID: 15809732

3

Global and regional CpG methylation in pheochromocytomas and abdominal paragangliomas: association to malignant behavior.

Geli J, Kiss N, Karimi M, Lee JJ, Bäckdahl M, Ekström TJ, Larsson C. Geli J, et al. Clin Cancer Res. 2008 May 1;14(9):2551-9. doi: 10.1158/1078-0432.CCR-07-1867. Clin Cancer Res. 2008. PMID: 18451216

4

Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma.

Geli J, Kogner P, Lanner F, Natalishvili N, Juhlin C, Kiss N, Clark GJ, Ekström TJ, Farnebo F, Larsson C. Geli J, et al. Int J Cancer. 2008 Jul 15;123(2):389-394. doi: 10.1002/ijc.23533. Int J Cancer. 2008. PMID: 18452173 Free article.

5

Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas.

Kiss NB, Geli J, Lundberg F, Avci C, Velazquez-Fernandez D, Hashemi J, Weber G, Höög A, Ekström TJ, Bäckdahl M, Larsson C. Kiss NB, et al. Among authors: geli j. Endocr Relat Cancer. 2008 Jun;15(2):609-21. doi: 10.1677/ERC-07-0285. Endocr Relat Cancer. 2008. PMID: 18509008

6

The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma.

Geli J, Kiss N, Lanner F, Foukakis T, Natalishvili N, Larsson O, Kogner P, Höög A, Clark GJ, Ekström TJ, Bäckdahl M, Farnebo F, Larsson C. Geli J, et al. Endocr Relat Cancer. 2007 Mar;14(1):125-34. doi: 10.1677/ERC-06-0031. Endocr Relat Cancer. 2007. PMID: 17395981

7

Suppression of RIZ in biologically unfavourable neuroblastomas.

Geli J, Kiss N, Kogner P, Larsson C. Geli J, et al. Int J Oncol. 2010 Nov;37(5):1323-30. doi: 10.3892/ijo_00000784. Int J Oncol. 2010. PMID: 20878080

8

Acquired hypermethylation of the P16INK4A promoter in abdominal paraganglioma: relation to adverse tumor phenotype and predisposing mutation.

Kiss NB, Muth A, Andreasson A, Juhlin CC, Geli J, Bäckdahl M, Höög A, Wängberg B, Nilsson O, Ahlman H, Larsson C. Kiss NB, et al. Among authors: geli j. Endocr Relat Cancer. 2013 Feb 18;20(1):65-78. doi: 10.1530/ERC-12-0267. Print 2013 Feb. Endocr Relat Cancer. 2013. PMID: 23154831 Free PMC article.

9

Gene-specific promoter hypermethylation without global hypomethylation in follicular thyroid cancer.

Lee JJ, Geli J, Larsson C, Wallin G, Karimi M, Zedenius J, Höög A, Foukakis T. Lee JJ, et al. Among authors: geli j. Int J Oncol. 2008 Oct;33(4):861-9. Int J Oncol. 2008. PMID: 18813801

10

Transcriptional profiling enables molecular classification of adrenocortical tumours.

Laurell C, Velázquez-Fernández D, Lindsten K, Juhlin C, Enberg U, Geli J, Höög A, Kjellman M, Lundeberg J, Hamberger B, Larsson C, Nilsson P, Bäckdahl M. Laurell C, et al. Among authors: geli j. Eur J Endocrinol. 2009 Jul;161(1):141-52. doi: 10.1530/EJE-09-0068. Epub 2009 May 1. Eur J Endocrinol. 2009. PMID: 19411298

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page